Conflict of interest declaration: Paul Garner

Updated on: 29 April 2021

Roles in: Infectious Diseases Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the CRG?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the CRG?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the CRG?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the CRG?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - PG is director of the Research and Evidence for Development Initiative (READ-It, project number 300342-104) funded by UK aid from the UK government. Part of his salary is paid for from this grant, and much of his academic standing relates to outputs from this grant and from evidence synthesis. READ-It aims to to increase the number of evidence-informed decisions by intermediary organisations that benefit the poor in low and middle income countries (LMICs). DFID key performance indicators for READ-It include Cochrane Review production. PG is also the co-ordinator of a World Health Organization Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases (UNK306; apps.who.int/whocc); one of the Centre's aims is to prepare reliable systematic reviews to inform WHO policy. He is also a member of the Cochrane Editorial Board.